Select Medical Holdings Corp. (NYSE:SEM) shares rose 14.1% during mid-day trading on Friday . The stock traded as high as $12.50 and last traded at $12.32, with a volume of 748,073 shares. The stock had previously closed at $10.80.

SEM has been the subject of a number of research analyst reports. Zacks Investment Research cut Select Medical Holdings Corp. from a “buy” rating to a “hold” rating in a research report on Wednesday, May 11th. Robert W. Baird reissued a “hold” rating on shares of Select Medical Holdings Corp. in a research report on Monday, May 16th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Select Medical Holdings Corp. presently has an average rating of “Buy” and a consensus price target of $14.00.

The stock has a market capitalization of $1.61 billion and a PE ratio of 10.75. The firm’s 50-day moving average is $11.17 and its 200-day moving average is $11.18.

Select Medical Holdings Corp. (NYSE:SEM) last announced its quarterly earnings data on Thursday, August 4th. The company reported $0.23 EPS for the quarter, missing the Zacks’ consensus estimate of $0.24 by $0.01. The firm had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period in the prior year, the company earned $0.28 earnings per share. The business’s revenue was up 23.7% compared to the same quarter last year. On average, analysts predict that Select Medical Holdings Corp. will post $0.87 earnings per share for the current fiscal year.

In other news, Director James E. Dalton, Jr. sold 12,000 shares of the company’s stock in a transaction dated Monday, May 23rd. The shares were sold at an average price of $12.37, for a total transaction of $148,440.00. Following the completion of the transaction, the director now owns 95,979 shares of the company’s stock, valued at $1,187,260.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Other hedge funds and institutional investors recently made changes to their positions in the company. New York State Common Retirement Fund raised its position in shares of Select Medical Holdings Corp. by 4.7% in the fourth quarter. New York State Common Retirement Fund now owns 100,400 shares of the company’s stock worth $1,196,000 after buying an additional 4,500 shares in the last quarter. Rhumbline Advisers raised its position in shares of Select Medical Holdings Corp. by 9.3% in the fourth quarter. Rhumbline Advisers now owns 121,833 shares of the company’s stock worth $1,451,000 after buying an additional 10,360 shares in the last quarter. First Trust Advisors LP raised its position in shares of Select Medical Holdings Corp. by 12.9% in the fourth quarter. First Trust Advisors LP now owns 139,474 shares of the company’s stock worth $1,661,000 after buying an additional 15,887 shares in the last quarter. Royce & Associates LLC raised its position in shares of Select Medical Holdings Corp. by 15.9% in the fourth quarter. Royce & Associates LLC now owns 190,000 shares of the company’s stock worth $2,263,000 after buying an additional 26,000 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in shares of Select Medical Holdings Corp. during the fourth quarter worth approximately $7,236,000.

Select Medical Holdings Corporation is an operator of specialty hospitals and outpatient rehabilitation clinics. The Company, through its contract therapy business, provides medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.